Krumholz, Harlan M.
Yale New Haven Hospital · Yale University
95 papers on CoChatORCID 0000-0003-2046-127X
Most cited papers
- Verified
Blockchain Technology: Applications in Health Care
Angraal, S., Krumholz, H. M., & Schulz, W. L. (2017) · Circulation Cardiovascular Quality and Outcomes
Blockchain Technology Applications and SecurityBlockchain Technology in Education and Learning
Cited by 430
- Verified
Trial Publication after Registration in ClinicalTrials.Gov: A Cross-Sectional Analysis
Ross, J. S., Mulvey, G. K., Hines, E. M., Nissen, S. E., & Krumholz, H. M. (2009) · PLoS Medicine
Pharmaceutical industry and healthcareMeta-analysis and systematic reviews
Cited by 401
- Verified
Analysis of machine learning techniques for heart failure readmissions
Mortazavi, B. J., Downing, N. S., Bucholz, E. M., Dharmarajan, K., Manhapra, A., Li, S.-X., Negahban, S. N., & Krumholz, H. M. (2016) · Circulation: Cardiovascular Quality and Outcomes
Artificial Intelligence in HealthcareHeart Failure Treatment and Management
Cited by 401
- Verified · note
Glucometrics in Patients Hospitalized With Acute Myocardial Infarction: Defining the Optimal Outcomes-Based Measure of Risk
Kosiborod, M., Inzucchi, S. E., Krumholz, H. M., Xiao, L., Jones, P. G., Fiske, S., Masoudi, F. A., Marso, S. P., & Spertus, J. A. (2008) · Circulation
Hyperglycemia and glycemic control in critically ill and hospitalized patientsAcute Myocardial Infarction Research
Cited by 385
- Verified
Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis
Ross, J. S., Tse, T., Zarin, D. A., Xu, H., Zhou, L., & Krumholz, H. M. (2012) · BMJ
Academic Publishing and Open AccessPharmaceutical industry and healthcare
Cited by 371
- Verified
Trends in Differences in Health Status and Health Care Access and Affordability by Race and Ethnicity in the United States, 1999–2018
Mahajan, S., Caraballo, C., Lu, Y., Valero-Elizondo, J., Massey, D., Annapureddy, A. R., Roy, B., Riley, C., Murugiah, K., Onuma, O., et al. (2021) · JAMA
Health disparities and outcomesHealthcare Policy and Management
Cited by 368
- Verified
Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis
Suchard, M. A., Schuemie, M. J., Krumholz, H. M., You, S. C., Chen, R., Pratt, N., Reich, C. G., Duke, J., Madigan, D., Hripcsak, G., et al. (2019) · The Lancet
Blood Pressure and Hypertension StudiesCardiovascular Health and Disease Prevention
Cited by 359
- Verified
Digitizing clinical trials
Inan, O. T., Tenaerts, P., Prindiville, S. A., Reynolds, H. R., Dizon, D. S., Cooper-Arnold, K., Turakhia, M., Pletcher, M. J., Preston, K. L., Krumholz, H. M., et al. (2020) · npj Digital Medicine
Mobile Health and mHealth ApplicationsStatistical Methods in Clinical Trials
Cited by 329
- Verified
Management of Implantable Cardioverter Defibrillators in End-of-Life Care
Goldstein, N. E., Lampert, R., Bradley, E., Lynn, J., & Krumholz, H. M. (2004) · Annals of Internal Medicine
Palliative Care and End-of-Life IssuesCardiac pacing and defibrillation studies
Cited by 325
- Verified
Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010
Downing, N. S., Shah, N. D., Aminawung, J. A., Pease, A. M., Zeitoun, J.-D., Krumholz, H. M., & Ross, J. S. (2017) · JAMA
Pharmacovigilance and Adverse Drug ReactionsPharmaceutical Economics and Policy
Cited by 324
- Verified
Whole-Genome Sequencing to Characterize Monogenic and Polygenic Contributions in Patients Hospitalized With Early-Onset Myocardial Infarction
Khera, A. V., Chaffin, M., Zekavat, S. M., Collins, R. L., Roselli, C., Natarajan, P., Lichtman, J. H., D’Onofrio, G., Mattera, J., Dreyer, R., et al. (2019) · Circulation
Lipoproteins and Cardiovascular HealthGenetic Associations and Epidemiology
Cited by 315
- Verified
Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes
Lipska, K. J., Krumholz, H., Soones, T., & Lee, S. J. (2016) · JAMA
Diabetes Treatment and ManagementPharmaceutical Practices and Patient Outcomes
Cited by 309
- Verified
Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006–2013
Lipska, K. J., Yao, X., Herrin, J., McCoy, R. G., Ross, J. S., Steinman, M. A., Inzucchi, S. E., Gill, T. M., Krumholz, H. M., & Shah, N. D. (2017) · Diabetes Care
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 306
- Verified
Transfers of Patient Care Between House Staff on Internal Medicine Wards: A National Survey
Horwitz, L. I., Krumholz, H. M., Green, M. L., & Huot, S. J. (2006) · Archives of Internal Medicine
Hospital Admissions and OutcomesPatient Safety and Medication Errors
Cited by 286
- Verified
Reevaluating the Efficacy and Predictability of Antidepressant Treatments: A Symptom Clustering Approach
Chekroud, A. M., Gueorguieva, R., Krumholz, H. M., Trivedi, M. H., Krystal, J. H., & McCarthy, G. (2017) · JAMA Psychiatry
Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 276
- Verified
What have we learnt from Vioxx?
Krumholz, H. M., Ross, J. S., Presler, A. H., & Egilman, D. S. (2007) · BMJ
Inflammatory mediators and NSAID effectsPharmacovigilance and Adverse Drug Reactions
Cited by 267
- Verified
Risk factors for heart failure in the elderly: a prospective community-based study
Chen, Y.-T., Vaccarino, V., Williams, C. S., Butler, J., Berkman, L. F., & Krumholz, H. M. (1999) · The American Journal of Medicine
Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors
Cited by 256
- Verified
Illusory generalizability of clinical prediction models
Chekroud, A. M., Hawrilenko, M., Loho, H., Bondar, J., Gueorguieva, R., Hasan, A., Kambeitz, J., Corlett, P. R., Koutsouleris, N., Krumholz, H. M., et al. (2024) · Science
Machine Learning in HealthcareSchizophrenia research and treatment
Cited by 251
- Verified
Effect of Blinded Peer Review on Abstract Acceptance
Ross, J. S., Gross, C. P., Desai, M. M., Hong, Y., Grant, A. O., Daniels, S. R., Hachinski, V. C., Gibbons, R. J., Gardner, T. J., & Krumholz, H. M. (2006) · JAMA
Academic Writing and PublishingAcademic Publishing and Open Access
Cited by 250
- Verified
The New Era of Informed Consent: Getting to a Reasonable-Patient Standard Through Shared Decision Making
Spatz, E. S., Krumholz, H. M., & Moulton, B. W. (2016) · JAMA
Ethics and bioethics in healthcarePatient-Provider Communication in Healthcare
Cited by 236
- Verified
Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy
Smith, G. L., Smith, B. D., Buchholz, T. A., Giordano, S. H., Garden, A. S., Woodward, W. A., Krumholz, H. M., Weber, R. S., Ang, K.-K., & Rosenthal, D. I. (2008) · Journal of Clinical Oncology
Head and Neck Cancer StudiesCerebrovascular and Carotid Artery Diseases
Cited by 231
- Verified
Telemonitoring for Patients With Chronic Heart Failure: A Systematic Review
Chaudhry, S. I., Phillips, C. O., Stewart, S. S., Riegel, B., Mattera, J. A., Jerant, A. F., & Krumholz, H. M. (2007) · Journal of Cardiac Failure
Heart Failure Treatment and ManagementTelemedicine and Telehealth Implementation
Cited by 231
- Verified
Cardiac Care for Older Adults
Forman, D. E., Rich, M. W., Alexander, K. P., Zieman, S., Maurer, M. S., Najjar, S. S., Cleveland, J. C., Krumholz, H. M., & Wenger, N. K. (2011) · Journal of the American College of Cardiology
Frailty in Older AdultsChronic Disease Management Strategies
Cited by 228
- Verified
Publication and reporting of clinical trial results: cross sectional analysis across academic medical centers
Chen, R., Desai, N. R., Ross, J. S., Zhang, W., Chau, K. H., Wayda, B., Murugiah, K., Lu, D. Y., Mittal, A., & Krumholz, H. M. (2016) · BMJ
Pharmaceutical industry and healthcareAcademic Publishing and Open Access
Cited by 227
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free